#Ireland #Dublin #LUMA Vision #VERAFEYE #Cardiac Technology

LUMA Vision Advances Cardiac Procedures with VERAFEYE™

LUMA Vision, a trailblazer in cardiac navigation and visualization technologies, has recently achieved a major milestone with the successful first-in-human procedures utilizing their innovative VERAFEYE™ navigation and visualization platform. This pivotal development is set to revolutionize the way clinicians perform interventional electrophysiology, offering unprecedented real-time imaging of cardiac anatomy.

On January 14, 2025, LUMA Vision proudly announced this accomplishment as part of their LUMINIZE clinical study. The VERAFEYE™ platform employs advanced four-dimensional catheter-based imaging technology, which tracks the navigation of third-party catheters through magnetic means. This capability allows doctors to conduct complex procedures with enhanced precision and control, significantly improving patient care.

Traditionally, medical imaging catheters have only provided two-dimensional images, which can limit clinicians during crucial procedures. In contrast, VERAFEYE™ introduces a groundbreaking approach, enabling comprehensive and dynamic 360-degree views of the heart's chambers. This advanced imaging system not only captures high-resolution images in real-time but also incorporates the Rapid Digital Anatomy (RDA) feature, facilitating the creation of CT-quality reconstructions of atrial chambers in less than a minute.

The initial procedures using this technology took place at the prestigious Mater Private Network in Dublin, under the expert supervision of the renowned Electrophysiologist, Professor Gabor Széplaki. During these procedures, the VERAFEYE™ system demonstrated its exceptional potential to enhance procedural workflows, accuracy, and overall control. Professor Széplaki emphasized, "The VERAFEYE™ system provides a level of detail and real-time spatial context that is unmatched by traditional imaging methods. This innovative technology represents a significant advancement in our capability to deliver precise and effective treatments for patients with intricate heart conditions."

The implications of this innovation are profound. By offering real-time volumetric imaging and interactive visualization, the VERAFEYE™ system empowers clinicians to make more informed decisions throughout procedures. This capability has the potential to reduce operation times and minimize associated risks for patients, providing a safer and more effective treatment approach.

Fionn Lahart, CEO of LUMA Vision, expressed enthusiasm regarding the future of cardiac care enabled by VERAFEYE™. "We are thrilled with this achievement and the new opportunities it presents in areas like cardiac arrhythmias and structural heart conditions. The development of VERAFEYE™ showcases our dedication to advancing medical technology. With impending market approval, we can equip healthcare providers with tools that enhance patient outcomes globally."

LUMA Vision, which operates out of Dublin, Ireland, and Munich, Germany, is committed to innovating medical devices that address significant global healthcare needs. The VERAFEYE™ platform offers a novel approach to cardiac navigation and visualization, capable of generating comprehensive views and imaging all anatomical structures surrounding the catheter with remarkable clarity and depth.

In summary, LUMA Vision's VERAFEYE™ platform marks a significant leap forward in cardiac visualization, promising to refine procedural accuracy and improve patient outcomes. As the world of medical technology progresses, LUMA Vision stands at the forefront of these advancements, driven by a mission to enhance clinical practices and improve livelihoods worldwide.